血清钙相关遗传变异与骨密度降低的关联
CONTEXT: The role of serum calcium in bone metabolism is unknown, even though calcium/vitamin D supplementations have been widely used and are expected to improve bone health. We aim to determine the independent role of serum calcium in bone mineral density (BMD).…
要点
- 血清钙每升高1个标准差,多部位骨密度降低0.036-0.092个标准差(均P<.05)。
- 高剂量钙/维生素D补充对骨代谢的负性影响尚不明确,需谨慎使用。
核心结论
- 遗传预测的较高血清钙水平本身可能对骨代谢有负面影响。
研究设计与样本
- 横断面流行病学分析纳入NHANES 2003-2006的5478人和香港骨质疏松研究的5556人,评估血清钙与骨密度的关联。
主要发现
- 在NHANES 2003-6和HKOS中,血清钙每升高1个标准差与多部位骨密度降低0.036-0.092个标准差显著相关(均P<.05)。
- 敏感性分析获得相似估计。
临床怎么用
- 临床应关注血清钙水平对骨密度的潜在独立负性影响。
- 高剂量钙/维生素D补充剂的使用需谨慎,尤其需权衡对骨代谢的可能不利影响。
局限性
- 钙/维生素D补充剂导致的血清钙升高是否对骨有相同负面效应尚不清楚,需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The role of serum calcium in bone metabolism is unknown, even though calcium/vitamin D supplementations have been widely used and are expected to improve bone health. We aim to determine the independent role of serum calcium in bone mineral density (BMD). DESIGN AND SETTING: Two epidemiological analyses with 5478 and 5556 participants from the National Health and Nutrition Examination Survey (NHANES) 2003 to 2006 and the Hong Kong Osteoporosis Study (HKOS) to evaluate the cross-sectional association of serum calcium with BMD. Two-sample Mendelian randomization (MR) studies using genetic variations as instrumental variables to infer causality. Summary statistics of genome-wide association study of serum calcium (N = 39 400) and lifelong whole-body BMD (N = 66 628) were used. MAIN OUTCOME MEASURE: BMD measured by dual-energy X-ray absorptiometry. RESULTS: In NHANES 2003-6 and HKOS, each standard deviation (SD) increase in serum calcium was significantly associated with 0.036-0.092 SD decrease in BMD at various sites (all P < .05). In multivariable inverse-variance weighted MR analysis, genetic predisposition to higher serum calcium level was inversely associated with whole-body BMD after adjustment for serum parathyroid hormone, vitamin D, and phosphate (-0.431 SD per SD increase in serum calcium; 95% CI: -0.773 to -0.089, P = .014). Similar estimates were obtained in sensitivity analyses. CONCLUSIONS: Our study reveals that genetic predisposition to higher serum calcium level per se may have a negative impact on bone metabolism. Whether increased serum calcium caused by calcium/vitamin D supplementations would have the same negative effect on bone remains unknown, which warrants further investigation. In addition to other adverse clinical outcomes, careful use of high-dose supplementations is required.
引用
- Li GH, Robinson-Cohen C, Sahni S, et al. Association of Genetic Variants Related to Serum Calcium Levels with Reduced Bone Mineral Density. J Clin Endocrinol Metab. 2020. PMID: 31650181. doi:10.1210/clinem/dgz088
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。